Feed NSPR
NS

InspireMD, Inc.

NSPR · NASDAQ

$0.79 +1.28% (+$0.01)
1M -10.22%
Market Cap $39.5M
P/E Ratio -
Div. Yield -
ROE 79.21%
Piotroski F-Score Weak
2/9
Valuation
75 /100
Cheap
P/B 1.25x
P/S 3.64x
P/FFO N/A
Growth
100 /100
Growing
Book val. growth 46.96%
Rev. growth 20.19%
FCF growth N/A
Profitability
5 /100
Weak
Op. margin 494.03%
Gross margin 18.05%
FCF margin 391.67%
Quality
3 /100
Poor
ROA 86.25%
ROIC 153.30%
Asset turnover 0.24x
Debt
100 /100
Low
Current ratio 3.80x
Debt/Equity 0.06x
Debt/Assets N/A
Stability
73 /100
Stable
EPS volatility 35.67%
Beta 0.82x
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about NSPR
Online

Sector

Healthcare

Industry

Medical - Devices

CEO

Marvin L. Slosman

Employees

127

Headquarters

Miami

Upcoming events

10 NOV

Earnings

Upcoming earnings report

57d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.